Paasa Logo

NASDAQ · Healthcare

Invest in Veraxa Biotech stock from India

Indian and foreign residents can buy Veraxa Biotech (VRXA) shares directly through Paasa.

By Paasa · Updated

Veraxa Biotech at a glance

Price
$1.31-$0.06 (4.38%)
Market cap
$185.24M
Day range
$1.30 – $1.37
P/E
—
Dividend yield
None
Volume
52.77K

Live chart and statistics

How to invest in Veraxa Biotech from India

  1. Step 1

    Open your Paasa account

    KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Step 2

    Add funds from your Indian bank account

    Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.

  3. Step 3

    Search VRXA and buy

    Find Veraxa Biotech by name or by its ticker, VRXA, and place your order. Fractional shares are available and there is no minimum trade size, so you can buy by amount instead of whole shares.

Why invest in Veraxa Biotech from India

What Veraxa Biotech does

Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Veraxa Biotech operates in the Biotechnology industry within the Healthcare sector.

Hold a dollar asset

Veraxa Biotech shares are priced in US dollars, so a weaker rupee adds to what they're worth in rupees. The rupee depreciated over 85% against the dollar between 2010 and 2025.

Buy a fraction of a share

Buy by amount, not by share, and get the matching fraction of one Veraxa Biotech share. There is no minimum trade size.

Paasa handles the paperwork

Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.

Frequently asked questions

Can I buy Veraxa Biotech stock from India?

Yes. Indian residents and NRIs can buy Veraxa Biotech (VRXA) shares directly through Paasa. Veraxa Biotech is listed on NASDAQ, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.

Do I need to buy a full Veraxa Biotech share?

No. You can buy part of one Veraxa Biotech share and add to your position over time. One share is $1.31, and you can buy whole shares or any fraction; there is no minimum trade size.

How are Veraxa Biotech dividends taxed for Indian investors?

Veraxa Biotech trades on NASDAQ but is domiciled in Germany, so any withholding on its dividends follows that country's rules rather than those of the US. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.

What tax do I pay in India when I sell Veraxa Biotech shares?

The US does not levy capital gains tax on shares for Indian residents. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the USD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.

Share this guide
Get started

Build wealth in dollars, safeguard against rupee depreciation

Book a short call with our team to understand how Paasa can work for you